OABI
OmniAb, Inc.
Company overview
- Market capitalization
- $689.15M
- Employees
- 89
- Latest publication
- 2026-09-29
About OmniAb, Inc.
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company offers animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. It has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 13,415,000USD | 3,897,000USD | 4,154,000USD | 10,804,000USD | 4,172,000USD | 7,614,000USD | 3,801,000USD | 4,822,000USD |
| Research Development | 9,586,000USD | 10,864,000USD | 12,602,000USD | 13,306,000USD | 13,318,000USD | 13,935,000USD | 14,551,000USD | 14,766,000USD |
| Selling General Administrative | 6,653,000USD | 7,684,000USD | 7,915,000USD | 7,360,000USD | 7,079,000USD | 7,965,000USD | 8,337,000USD | 7,869,000USD |
| General And Administrative Expenses | 6,653,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 20,052,000USD | 19,854,000USD | 22,998,000USD | 26,684,000USD | 23,936,000USD | 23,919,000USD | 26,354,000USD | 26,028,000USD |
| Operating Income | -6,637,000USD | -16,219,000USD | -18,844,000USD | -15,880,000USD | -19,764,000USD | -16,305,000USD | -22,553,000USD | -21,206,000USD |
| Total Other Income Expense Net | 425,000USD | 463,000USD | 538,000USD | 657,000USD | 683,000USD | 776,000USD | 975,000USD | 1,178,000USD |
| Interest Income | 434,000USD | 436,000USD | 537,000USD | 655,000USD | 691,000USD | 785,000USD | 975,000USD | 1,181,000USD |
| Income Before Tax | -6,212,000USD | -15,756,000USD | -18,306,000USD | -15,223,000USD | -19,081,000USD | -15,529,000USD | -21,578,000USD | -20,028,000USD |
| Income Tax Expense | -353,000USD | 119,000USD | -106,000USD | -2,155,000USD | -2,708,000USD | -1,898,000USD | -2,617,000USD | -5,975,000USD |
| Net Income | -5,859,000USD | -15,875,000USD | -18,200,000USD | -13,068,000USD | -16,373,000USD | -13,631,000USD | -18,961,000USD | -14,053,000USD |
| Cost Of Revenue | — | 262,000USD | 3,000USD | 11,050,000USD | — | 6,101,000USD | 4,949,000USD | 4,934,000USD |
| Gross Profit | — | 3,635,000USD | 4,154,000USD | 10,804,000USD | 4,172,000USD | 7,614,000USD | 3,801,000USD | 4,822,000USD |
| Unclassified Operating Expenses | — | 1,306,000USD | 2,481,000USD | 4,481,000USD | 3,539,000USD | — | 1,929,000USD | 1,866,000USD |
| Net Interest Income | — | 436,000USD | 537,000USD | 655,000USD | 691,000USD | 785,000USD | 975,000USD | 1,181,000USD |
| Tax Provision | — | 119,000USD | -106,000USD | -2,155,000USD | -2,708,000USD | -1,898,000USD | -2,617,000USD | -5,975,000USD |
| Net Income From Continuing Ops | — | -15,875,000USD | -18,200,000USD | -13,068,000USD | -16,373,000USD | -13,631,000USD | -18,961,000USD | -14,053,000USD |
| Ebit | — | -19,219,000USD | -18,306,000USD | -15,223,000USD | -19,081,000USD | -15,529,000USD | -21,578,000USD | -20,028,000USD |
| Ebitda | — | -14,570,000USD | -13,563,000USD | -7,617,000USD | -14,154,000USD | -9,428,000USD | -16,629,000USD | -15,094,000USD |
| Depreciation And Amortization | — | 4,649,000USD | 4,743,000USD | 7,606,000USD | 4,927,000USD | 6,101,000USD | 4,949,000USD | 4,934,000USD |
| Reconciled Depreciation | — | 4,649,000USD | 4,743,000USD | 7,606,000USD | 4,927,000USD | 6,101,000USD | 4,949,000USD | 4,934,000USD |
| Selling And Marketing Expenses | — | — | — | 1,537,000USD | — | 1,558,000USD | 1,537,000USD | 1,527,000USD |
| Interest Expense | — | — | — | 3,106,000USD | — | — | — | 1,324,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 26,391,000USD | 34,164,000USD | 59,077,000USD | 34,748,000USD | 23,268,000USD | 18,318,000USD |
| Cost Of Revenue | 19,683,000USD | 19,497,000USD | 16,250,000USD | 14,968,000USD | — | — |
| Gross Profit | 26,391,000USD | 34,164,000USD | 59,077,000USD | 34,748,000USD | 23,268,000USD | 18,318,000USD |
| Research Development | 55,110,000USD | 56,525,000USD | 48,364,000USD | 39,232,000USD | 24,796,000USD | 13,208,000USD |
| Selling General Administrative | 30,741,000USD | 33,313,000USD | 24,903,000USD | 16,947,000USD | 10,225,000USD | 8,651,000USD |
| Unclassified Operating Expenses | 15,042,000USD | 7,802,000USD | 12,458,000USD | 14,178,000USD | 13,870,000USD | 9,486,000USD |
| Total Operating Expenses | 100,893,000USD | 103,583,000USD | 85,725,000USD | 70,357,000USD | 48,891,000USD | 31,345,000USD |
| Operating Income | -74,502,000USD | -69,419,000USD | -26,648,000USD | -35,609,000USD | -25,623,000USD | -13,027,000USD |
| Interest Income | 3,106,000USD | 4,461,000USD | 587,000USD | 0USD | — | — |
| Net Interest Income | 3,106,000USD | 4,461,000USD | 587,000USD | -7,000USD | -5,000USD | 0USD |
| Income Before Tax | -71,411,000USD | -64,363,000USD | -26,061,000USD | -34,350,000USD | -23,728,000USD | -13,027,000USD |
| Income Tax Expense | -9,378,000USD | -13,744,000USD | -3,727,000USD | -7,308,000USD | -6,171,000USD | 562,000USD |
| Tax Provision | -9,378,000USD | -4,952,000USD | -3,727,000USD | -7,308,000USD | -6,171,000USD | 562,000USD |
| Net Income | -62,033,000USD | -50,619,000USD | -22,334,000USD | -27,042,000USD | -17,557,000USD | -13,589,000USD |
| Net Income From Continuing Ops | -62,033,000USD | -29,746,000USD | -22,334,000USD | -27,042,000USD | -17,557,000USD | -13,589,000USD |
| Ebit | -71,411,000USD | -64,363,000USD | -26,061,000USD | -34,343,000USD | -23,553,000USD | -13,845,000USD |
| Ebitda | -47,828,000USD | -44,866,000USD | -7,812,000USD | -18,091,000USD | -10,926,000USD | -3,252,000USD |
| Depreciation And Amortization | 23,583,000USD | 19,497,000USD | 18,249,000USD | 16,252,000USD | 12,627,000USD | 10,593,000USD |
| Reconciled Depreciation | 23,583,000USD | 19,383,000USD | 13,050,000USD | 16,252,000USD | 13,137,000USD | 10,917,000USD |
| Total Other Income Expense Net | 3,091,000USD | 5,056,000USD | 587,000USD | 1,259,000USD | 1,895,000USD | 818,000USD |
| Selling And Marketing Expenses | — | 5,943,000USD | — | — | — | — |
| Interest Expense | — | — | 587,000USD | 7,000USD | 5,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | -22,334,000USD | -27,042,000USD | -17,557,000USD | -13,589,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 290,257,000USD | 293,650,000USD | 300,914,000USD | 309,690,000USD | 295,674,000USD | 306,182,000USD | 325,558,000USD | 331,554,000USD |
| Cash And Equivalents | 24,336,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 66,013,000USD | 65,125,000USD | 65,341,000USD | 66,349,000USD | 47,618,000USD | 53,578,000USD | 68,138,000USD | 66,609,000USD |
| Other Current Assets | 773,000USD | 3,414,000USD | 3,926,000USD | 3,311,000USD | 3,297,000USD | 3,505,000USD | 3,432,000USD | 3,733,000USD |
| Other Non Current Assets | 701,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 29,983,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 13,758,000USD | 13,566,000USD | 16,254,000USD | 13,277,000USD | 12,638,000USD | 11,407,000USD | 15,088,000USD | 14,402,000USD |
| Other Current Liabilities | 4,499,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 69,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 260,274,000USD | 262,646,000USD | 267,027,000USD | 277,444,000USD | 262,064,000USD | 273,516,000USD | 287,618,000USD | 291,728,000USD |
| Total Equity Including Noncontrolling Interest | 260,274,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 2,258,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 309,000USD | — | — | — | — | — | — | — |
| Net Receivables | 10,328,000USD | 12,639,000USD | 7,390,000USD | 3,095,000USD | 2,706,000USD | 6,478,000USD | 5,272,000USD | 3,495,000USD |
| Inventory | 1,013,000USD | 920,000USD | — | 443,000USD | — | — | — | — |
| Property Plant Equipment Net | 22,936,000USD | 24,070,000USD | 24,973,000USD | 29,397,000USD | 30,746,000USD | 31,950,000USD | 33,281,000USD | 34,666,000USD |
| Goodwill | 83,979,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 116,068,000USD | 119,121,000USD | 125,149,000USD | 128,377,000USD | 131,605,000USD | 134,833,000USD | 138,060,000USD | 144,119,000USD |
| Accounts Payable | 2,088,000USD | 1,652,000USD | 1,879,000USD | 1,908,000USD | 1,977,000USD | 1,933,000USD | 2,297,000USD | 2,187,000USD |
| Short Term Debt | 3,973,000USD | 3,940,000USD | 3,879,000USD | 3,861,000USD | 3,844,000USD | 3,813,000USD | 3,782,000USD | 3,751,000USD |
| Common Stock | 15,000USD | 14,000USD | 14,000USD | 14,000USD | 12,000USD | 12,000USD | 12,000USD | 12,000USD |
| Retained Earnings | -179,745,000USD | -173,886,000USD | -166,179,000USD | -152,000,000USD | -135,475,000USD | -119,600,000USD | -101,400,000USD | -88,332,000USD |
| Accumulated Other Comprehensive Income | -20,000USD | -2,000USD | 12,000USD | 5,000USD | -2,000USD | 8,000USD | 27,000USD | 49,000USD |
| Total Liab | — | 31,004,000USD | 33,887,000USD | 32,246,000USD | 33,610,000USD | 32,666,000USD | 37,940,000USD | 39,826,000USD |
| Other Current Liab | — | 5,033,000USD | 7,335,000USD | 5,873,000USD | 5,834,000USD | 3,935,000USD | 6,672,000USD | 5,956,000USD |
| Capital Stock | — | 14,000USD | 14,000USD | 14,000USD | 12,000USD | 12,000USD | 12,000USD | 12,000USD |
| Good Will | — | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD |
| Cash | — | 29,046,000USD | 25,524,000USD | 28,537,000USD | 18,281,000USD | 10,892,000USD | 27,598,000USD | 27,236,000USD |
| Cash And Short Term Investments | — | 49,072,000USD | 54,025,000USD | 59,500,000USD | 41,615,000USD | 43,595,000USD | 59,434,000USD | 59,381,000USD |
| Current Deferred Revenue | — | 2,941,000USD | 3,161,000USD | 1,635,000USD | 983,000USD | 1,726,000USD | 2,337,000USD | 2,508,000USD |
| Net Debt | — | -9,376,000USD | -5,190,000USD | -7,468,000USD | 3,502,000USD | 11,587,000USD | -4,434,000USD | -3,397,000USD |
| Short Long Term Debt Total | — | 19,670,000USD | 20,334,000USD | 21,069,000USD | 21,783,000USD | 22,479,000USD | 23,164,000USD | 23,839,000USD |
| Short Term Investments | — | 20,026,000USD | 28,501,000USD | 30,963,000USD | 23,334,000USD | 32,703,000USD | 31,836,000USD | 32,145,000USD |
| Property Plant Equipment Gross | — | 44,008,000USD | 44,305,000USD | 44,990,000USD | 45,477,000USD | 45,818,000USD | 46,182,000USD | 46,620,000USD |
| Common Stock Shares Outstanding | — | 128,333,333shares | 127,789,000shares | 114,726,000shares | 106,148,000shares | 105,622,000shares | 104,795,000shares | 102,393,000shares |
| Non Current Assets Total | — | 228,525,000USD | 235,573,000USD | 243,341,000USD | 248,056,000USD | 252,604,000USD | 257,420,000USD | 264,945,000USD |
| Non Current Liabilities Total | — | 17,438,000USD | 17,633,000USD | 18,969,000USD | 20,972,000USD | 21,259,000USD | 22,852,000USD | 25,424,000USD |
| Non Current Liabilities Other | — | 112,000USD | 393,000USD | 595,000USD | 664,000USD | 385,000USD | 1,039,000USD | 1,164,000USD |
| Non Currrent Assets Other | — | 1,355,000USD | 1,472,000USD | 1,588,000USD | 1,726,000USD | 1,842,000USD | 2,100,000USD | 2,181,000USD |
| Net Working Capital | — | 51,559,000USD | 49,087,000USD | 53,072,000USD | 34,980,000USD | 42,171,000USD | 53,050,000USD | 52,207,000USD |
| Unclassified Non Current Liabilities | — | 17,326,000USD | 17,240,000USD | 18,374,000USD | 20,308,000USD | 20,874,000USD | 21,813,000USD | 24,260,000USD |
| Unclassified Equity | — | 436,506,000USD | 433,166,000USD | 429,411,000USD | 397,517,000USD | 393,084,000USD | 388,967,000USD | 379,987,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 300,914,000USD | 325,558,000USD | 375,225,000USD | 421,212,000USD | 304,465,000USD | 295,380,000USD | 262,320,000USD |
| Intangible Assets | 125,149,000USD | 138,060,000USD | 155,467,000USD | 167,242,000USD | 176,321,000USD | 186,644,000USD | 172,982,000USD |
| Other Current Assets | 3,926,000USD | 3,432,000USD | 4,074,000USD | 6,395,000USD | 1,406,000USD | 774,000USD | 21,000USD |
| Total Liab | 33,887,000USD | 37,940,000USD | 60,640,000USD | 79,839,000USD | 70,158,000USD | 59,843,000USD | 44,135,000USD |
| Total Stockholder Equity | 267,027,000USD | 287,618,000USD | 314,585,000USD | 341,373,000USD | 234,307,000USD | 235,537,000USD | 218,185,000USD |
| Other Current Liab | 7,335,000USD | 7,139,000USD | 8,371,000USD | 9,579,000USD | 6,285,000USD | 6,071,000USD | 5,033,000USD |
| Common Stock | 14,000USD | 12,000USD | 12,000USD | 12,000USD | 234,307,000USD | 235,537,000USD | 218,185,000USD |
| Capital Stock | 14,000USD | 12,000USD | 12,000USD | 12,000USD | 0USD | — | — |
| Retained Earnings | -166,179,000USD | -101,400,000USD | -39,367,000USD | 11,252,000USD | 0USD | — | — |
| Good Will | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 83,979,000USD | 77,108,000USD |
| Cash | 25,524,000USD | 27,598,000USD | 16,358,000USD | 33,390,000USD | -13,851,000USD | -2,592,000USD | — |
| Cash And Short Term Investments | 54,025,000USD | 59,434,000USD | 86,983,000USD | 88,265,000USD | -13,851,000USD | -2,592,000USD | — |
| Total Current Assets | 65,341,000USD | 68,138,000USD | 94,901,000USD | 124,950,000USD | 22,542,000USD | 16,649,000USD | 7,795,000USD |
| Total Current Liabilities | 16,254,000USD | 15,088,000USD | 23,116,000USD | 26,022,000USD | 20,577,000USD | 14,277,000USD | 6,139,000USD |
| Current Deferred Revenue | 3,161,000USD | 2,337,000USD | 6,848,000USD | 8,207,000USD | 10,790,000USD | 7,157,000USD | — |
| Net Debt | -5,190,000USD | -4,434,000USD | 9,203,000USD | -7,594,000USD | 13,850,000USD | 2,592,000USD | 2,575,000USD |
| Short Term Debt | 3,879,000USD | 3,782,000USD | 3,486,000USD | 1,780,000USD | 578,000USD | 580,000USD | 300,000USD |
| Short Long Term Debt Total | 20,334,000USD | 23,164,000USD | 25,561,000USD | 25,796,000USD | 13,850,000USD | 2,592,000USD | 2,575,000USD |
| Short Term Investments | 28,501,000USD | 31,836,000USD | 70,625,000USD | 54,875,000USD | 0USD | — | — |
| Net Receivables | 7,390,000USD | 5,272,000USD | 3,844,000USD | 30,290,000USD | 21,136,000USD | 15,875,000USD | 7,774,000USD |
| Accounts Payable | 1,879,000USD | 2,297,000USD | 4,411,000USD | 2,971,000USD | 2,924,000USD | 469,000USD | 806,000USD |
| Property Plant Equipment Net | 24,973,000USD | 33,281,000USD | 38,133,000USD | 41,462,000USD | 20,127,000USD | 5,979,000USD | 4,320,000USD |
| Property Plant Equipment Gross | 44,305,000USD | 46,182,000USD | 47,009,000USD | 41,462,000USD | 23,419,000USD | 7,285,000USD | — |
| Accumulated Other Comprehensive Income | 12,000USD | 27,000USD | 50,000USD | 9,000USD | 234,307,000USD | — | — |
| Common Stock Shares Outstanding | 113,635,000shares | 102,365,000shares | 99,683,000shares | 85,318,000shares | 114,820,859shares | 114,820,859shares | 114,820,859shares |
| Non Current Assets Total | 235,573,000USD | 257,420,000USD | 280,324,000USD | 296,262,000USD | 281,923,000USD | 278,731,000USD | 254,525,000USD |
| Non Current Liabilities Total | 17,633,000USD | 22,852,000USD | 37,524,000USD | 53,817,000USD | 49,581,000USD | 45,566,000USD | 37,996,000USD |
| Non Current Liabilities Other | 393,000USD | 1,039,000USD | 3,233,000USD | 4,135,000USD | 5,121,000USD | 6,397,000USD | — |
| Non Currrent Assets Other | 1,472,000USD | 2,100,000USD | 2,745,000USD | 3,579,000USD | 1,496,000USD | 2,129,000USD | 115,000USD |
| Net Working Capital | 49,087,000USD | 53,050,000USD | 71,785,000USD | 98,928,000USD | 1,965,000USD | 2,372,000USD | — |
| Unclassified Non Current Liabilities | 17,240,000USD | 21,813,000USD | 34,291,000USD | 19,881,000USD | 8,151,000USD | -4,385,000USD | 2,275,000USD |
| Unclassified Equity | 433,166,000USD | 388,967,000USD | 353,878,000USD | 330,088,000USD | -234,307,000USD | — | — |
| Inventory | — | — | 1USD | — | 13,851,000USD | 2,592,000USD | — |
| Other Liab | — | — | — | 29,801,000USD | 36,309,000USD | 43,554,000USD | 35,721,000USD |
| Other Assets | — | — | — | 3,579,000USD | 1,496,000USD | 2,129,000USD | 115,000USD |
| Net Tangible Assets | — | — | — | 90,152,000USD | -25,993,000USD | -35,086,000USD | -31,905,000USD |
| Unclassified Non Current Assets | — | — | — | -3,579,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | 3,485,000USD | — | — | — |
| Unclassified Current Assets | — | — | — | — | -13,851,000USD | -2,592,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 10,300,000USD |
| Stock Based Compensation | 6,499,000USD |
| Deferred Income Tax | 97,000USD |
| Other Non Cash Items | -63,000USD |
| Change To Account Receivables | -2,554,000USD |
| Change To Liabilities | -1,545,000USD |
| Change In Working Capital | -3,652,000USD |
| Operating Cash Flow | -2,235,000USD |
| Capital Expenditures | -277,000USD |
| Net Investments | 1,091,000USD |
| Investing Cash Flow | 814,000USD |
| Common Stock Issuance | 346,000USD |
| Unclassified Financing Cash Flow | -113,000USD |
| Financing Cash Flow | 233,000USD |
| Change In Cash | -1,188,000USD |
| End Cash Flow | 24,896,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,707,000USD | -14,179,000USD | -16,525,000USD | -15,875,000USD | -18,200,000USD | -13,068,000USD | -16,373,000USD | -13,631,000USD |
| Depreciation | 7,214,000USD | 7,707,000USD | 4,655,000USD | 4,649,000USD | 4,743,000USD | 7,606,000USD | 4,927,000USD | 6,101,000USD |
| Stock Based Compensation | 3,340,000USD | 3,606,000USD | 3,963,000USD | 4,111,000USD | 4,144,000USD | 5,116,000USD | 5,305,000USD | 5,383,000USD |
| Other Non Cash Items | -462,000USD | 488,000USD | -163,000USD | -2,046,000USD | -1,051,000USD | -330,000USD | -192,000USD | -2,384,000USD |
| Change To Account Receivables | -4,922,000USD | -2,180,000USD | -230,000USD | 3,069,000USD | -470,000USD | -1,888,000USD | 3,857,000USD | -2,726,000USD |
| Change In Working Capital | -7,741,000USD | -2,915,000USD | -532,000USD | 3,896,000USD | -5,402,000USD | -1,379,000USD | 2,463,000USD | -5,753,000USD |
| Total Cash From Operating Activities | -4,914,000USD | -5,674,000USD | -9,763,000USD | -5,146,000USD | -15,872,000USD | -3,872,000USD | -6,578,000USD | -12,182,000USD |
| Capital Expenditures | -167,000USD | -9,000USD | -182,000USD | -165,000USD | -209,000USD | -46,000USD | -152,000USD | -751,000USD |
| Free Cash Flow | -5,081,000USD | -5,683,000USD | -9,945,000USD | -5,311,000USD | -16,081,000USD | -3,918,000USD | -6,730,000USD | -12,933,000USD |
| Investments | 8,603,000USD | 2,720,000USD | -7,665,000USD | 12,299,000USD | -878,000USD | 385,000USD | 4,449,000USD | 13,113,000USD |
| Total Cashflows From Investing Activities | 8,436,000USD | 2,711,000USD | -7,665,000USD | 12,299,000USD | -878,000USD | 385,000USD | 4,449,000USD | 13,113,000USD |
| Total Cash From Financing Activities | 0USD | -50,000USD | 27,684,000USD | 236,000USD | 44,000USD | 3,849,000USD | 8,571,000USD | 803,000USD |
| Change In Cash | 3,522,000USD | -3,013,000USD | 10,256,000USD | 7,389,000USD | -16,706,000USD | 362,000USD | 6,442,000USD | 1,734,000USD |
| Begin Period Cash Flow | 26,084,000USD | 29,097,000USD | 18,841,000USD | 11,452,000USD | 28,158,000USD | 27,796,000USD | 21,354,000USD | 19,620,000USD |
| End Period Cash Flow | 29,606,000USD | 26,084,000USD | 29,097,000USD | 18,841,000USD | 11,452,000USD | 28,158,000USD | 27,796,000USD | 21,354,000USD |
| Issuance Of Capital Stock | — | 0USD | — | — | — | 2,889,000USD | — | — |
| Other Cashflows From Financing Activities | — | -198,000USD | 27,684,000USD | -61,000USD | 44,000USD | 960,000USD | 8,571,000USD | 803,000USD |
| Other Cashflows From Investing Activities | — | — | 3,000,000USD | 3,000,000USD | — | -1,443,000USD | 1,680,000USD | — |
| Unclassified Operating Cash Flow | — | — | -1,161,000USD | — | — | -1,817,000USD | -2,708,000USD | -1,898,000USD |
| Unclassified Investing Cash Flow | — | — | -2,818,000USD | -2,835,000USD | — | 1,489,000USD | -1,528,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | 960,000USD | — | -98,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 1,929,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -64,779,000USD | -62,033,000USD | -50,619,000USD | -22,334,000USD | -27,042,000USD | -17,557,000USD | -13,589,000USD |
| Depreciation | 21,754,000USD | 23,583,000USD | 19,497,000USD | 18,249,000USD | 16,252,000USD | 13,137,000USD | 10,917,000USD |
| Stock Based Compensation | 15,824,000USD | 21,499,000USD | 24,820,000USD | 18,322,000USD | 15,065,000USD | 9,165,000USD | 6,660,000USD |
| Other Non Cash Items | -2,772,000USD | -3,501,000USD | -3,682,000USD | -572,000USD | 9,000USD | 331,000USD | -818,000USD |
| Change To Account Receivables | 189,000USD | -625,000USD | 26,898,000USD | -12,737,000USD | 6,019,000USD | 339,000USD | -4,290,000USD |
| Change In Working Capital | -4,953,000USD | -10,172,000USD | 24,871,000USD | -10,833,000USD | -2,631,000USD | 4,728,000USD | -8,922,000USD |
| Total Cash From Operating Activities | -36,455,000USD | -39,664,000USD | 2,347,000USD | -3,587,000USD | -5,672,000USD | 3,619,000USD | -5,195,000USD |
| Capital Expenditures | -565,000USD | -1,875,000USD | -1,644,000USD | -17,168,000USD | -4,070,000USD | -1,753,000USD | -255,000USD |
| Free Cash Flow | -37,020,000USD | -41,539,000USD | 703,000USD | -20,755,000USD | -9,742,000USD | 1,866,000USD | -5,450,000USD |
| Investments | 4,032,000USD | 37,884,000USD | -83,307,000USD | -73,313,000USD | 1,265,000USD | 1,265,000USD | 1,265,000USD |
| Total Cashflows From Investing Activities | 6,467,000USD | 37,884,000USD | -18,376,000USD | -73,313,000USD | -4,025,000USD | -26,980,000USD | -12,095,000USD |
| Total Cash From Financing Activities | 27,914,000USD | 13,020,000USD | -892,000USD | 110,739,000USD | 9,697,000USD | 23,361,000USD | 17,290,000USD |
| Issuance Of Capital Stock | 28,199,000USD | 11,369,000USD | 97,667,000USD | 96,677,000USD | 0USD | — | — |
| Change In Cash | -2,074,000USD | 11,240,000USD | -16,921,000USD | 33,839,000USD | 9,697,000USD | 23,361,000USD | 17,290,000USD |
| Begin Period Cash Flow | 28,158,000USD | 16,918,000USD | 33,839,000USD | 0USD | 0USD | 0USD | 0USD |
| End Period Cash Flow | 26,084,000USD | 28,158,000USD | 16,918,000USD | 33,839,000USD | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | 3,000,000USD | -400,000USD | -4,440,000USD | -1,440,000USD | -1,220,000USD | 1,900,000USD | -1,220,000USD |
| Other Cashflows From Financing Activities | -450,000USD | 1,651,000USD | -892,000USD | 14,497,000USD | 9,697,000USD | 23,361,000USD | 17,290,000USD |
| Unclassified Operating Cash Flow | -1,529,000USD | -9,040,000USD | -12,540,000USD | -6,419,000USD | -7,325,000USD | -6,185,000USD | — |
| Unclassified Investing Cash Flow | — | 2,275,000USD | 71,015,000USD | 18,608,000USD | — | -28,392,000USD | -11,885,000USD |
| Sale Purchase Of Stock | — | — | -1,324,000USD | -189,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | 1,324,000USD | 96,431,000USD | — | — | — |
| Change To Liabilities | — | — | — | 5,579,000USD | -5,204,000USD | 4,087,000USD | -2,445,000USD |
| Change To Inventory | — | — | — | — | -1,513,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | License And Milestone Revenue | 9,515,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Royalty | 266,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Services | 2,473,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | XPloration Revenue | 1,161,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | License And Milestone Revenue | 12,025,000 | USD | 0001846253-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalty | 241,000 | USD | 0001846253-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 2,107,000 | USD | 0001846253-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | XPloration Revenue | 54,000 | USD | 0001846253-26-000037 |
| FY 2025Yearly · 2025-12-31 | Product | License And Milestone Revenue | 9,771,000 | USD | 0001846253-26-000009 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 878,000 | USD | 0001846253-26-000009 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 7,263,000 | USD | 0001846253-26-000009 |
| FY 2025Yearly · 2025-12-31 | Product | XPloration Revenue | 754,000 | USD | 0001846253-26-000009 |
| Q3 2025Quarterly · 2025-09-30 | Product | License And Milestone Revenue | 616,000 | USD | 0001628280-25-048923 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalty | 361,000 | USD | 0001628280-25-048923 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 1,188,000 | USD | 0001628280-25-048923 |
| Q3 2025Quarterly · 2025-09-30 | Product | XPloration Revenue | 74,000 | USD | 0001628280-25-048923 |
| Q2 2025Quarterly · 2025-06-30 | Product | License And Milestone Revenue | 1,242,000 | USD | 0001846253-25-000066 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalty | 111,000 | USD | 0001846253-25-000066 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 1,936,000 | USD | 0001846253-25-000066 |
| Q2 2025Quarterly · 2025-06-30 | Product | XPloration Revenue | 608,000 | USD | 0001846253-25-000066 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Milestone Revenue | 2,021,000 | USD | 0001846253-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalty | 188,000 | USD | 0001846253-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 1,903,000 | USD | 0001846253-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | XPloration Revenue | 42,000 | USD | 0001846253-26-000037 |
| FY 2024Yearly · 2024-12-31 | Product | License And Milestone Revenue | 13,866,000 | USD | 0001846253-26-000009 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 576,000 | USD | 0001846253-26-000009 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 11,949,000 | USD | 0001846253-26-000009 |
| FY 2024Yearly · 2024-12-31 | Product | XPloration Revenue | 0 | USD | 0001846253-26-000009 |
| Q3 2024Quarterly · 2024-09-30 | Product | License And Milestone Revenue | 1,375,000 | USD | 0001628280-25-048923 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalty | 318,000 | USD | 0001628280-25-048923 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 2,479,000 | USD | 0001628280-25-048923 |
| Q3 2024Quarterly · 2024-09-30 | Product | XPloration Revenue | 0 | USD | 0001628280-25-048923 |
| Q2 2024Quarterly · 2024-06-30 | Product | License And Milestone Revenue | 3,125,000 | USD | 0001846253-25-000066 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalty | 318,000 | USD | 0001846253-25-000066 |
| Q2 2024Quarterly · 2024-06-30 | Product | Services | 4,171,000 | USD | 0001846253-25-000066 |
| Q2 2024Quarterly · 2024-06-30 | Product | XPloration Revenue | 0 | USD | 0001846253-25-000066 |
| Q1 2024Quarterly · 2024-03-31 | Product | License And Milestone Revenue | 716,000 | USD | 0001846253-25-000055 |
| Q1 2024Quarterly · 2024-03-31 | Product | Royalty | 319,000 | USD | 0001846253-25-000055 |
| Q1 2024Quarterly · 2024-03-31 | Product | Services | 2,766,000 | USD | 0001846253-25-000055 |
| FY 2023Yearly · 2023-12-31 | Product | License And Milestone Revenue | 20,699,000 | USD | 0001846253-25-000024 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 1,285,000 | USD | 0001846253-25-000024 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 12,180,000 | USD | 0001846253-25-000024 |
| FY 2022Yearly · 2022-12-31 | Product | License | 5,055,000 | USD | 0001846253-23-000026 |
| FY 2022Yearly · 2022-12-31 | Product | Milestone | 33,871,000 | USD | 0001846253-23-000026 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 1,367,000 | USD | 0001846253-23-000026 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 18,784,000 | USD | 0001846253-23-000026 |
| FY 2021Yearly · 2021-12-31 | Product | License | 4,500,000 | USD | 0001846253-23-000026 |
| FY 2021Yearly · 2021-12-31 | Product | Milestone | 10,164,000 | USD | 0001846253-23-000026 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 0 | USD | 0001846253-23-000026 |
| FY 2021Yearly · 2021-12-31 | Product | Services | 20,084,000 | USD | 0001846253-23-000026 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.